Baudax Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Baudax Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2022.
  • Baudax Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $3.21M, a 64.6% decline year-over-year.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18.4M, a 57.1% decline from 2021.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.9M, a 25.2% decline from 2020.
  • Baudax Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $57.3M, a 17.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $18.4M -$24.5M -57.1% Jan 1, 2022 Dec 31, 2022 8-K 2023-06-28
2021 $42.9M -$14.4M -25.2% Jan 1, 2021 Dec 31, 2021 8-K 2023-06-28
2020 $57.3M -$12M -17.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $69.3M +$6.07M +9.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-16
2018 $63.2M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.